Financial history

 2011201020092008200720062005200420032002
Cochlear Implant system sales (units) 24,661 21,023 18,553 18,228 15,947 12,901 10,802 9,306 9,328 7,845
Income Statement ($m)
Total Revenue 809.6 734.8 694.7 601.7 559.4 452.3 349.0 282.8 306.1 255.0
R&D Expenditure 108.9 94.9 96.7 78.4 63.8 56.7 44.6 44.5 37.0 37.7**
EBITDA 270.1 243.6 205.5 193.3 170.9 130.2 96.8 54.9 87.9 56.2
EBIT 242.7 220.5 183.3 167.3 150.2 111.5 82.5 45.5 80.1 51.5
Profit after Income Tax 180.1 155.2 130.5 115.2 100.1 80.0 59.6 36.8 58.2 40.1
Balance Sheet ($m)
Total Assets 741.0 751.7 679.4 607.9 585.7 545.9 502.7 264.5 230.6 160.4
Total Liabilities 237.8 313.4 315.1 288.6 324.9 336.1 348.0 119.0 110.9 85.0
Statistics
EPS (cents) 318.2 275.7 233.7 208.1 182.9 146.8 110.1 68.2 110.0 76.6
DPS (cents) 225.0 200.0 175.0 150.0 125.0 100.0 80.0 79.0 77.0 51.0
Other Data
Closing Share Price ($) 72.00 74.32 57.70 43.65 61.00 54.63 39.20 22.72 32.30 34.05
Market Capitalisation
as at 30 June ($m)
4,081 4,198 3,230 2,423 3,341 2,985 2,123 1,231 1,714 1,788
Number of Employees 2,319 2,006 1,888 1,789 1,655 1,100 982 816 814 722

Financial amounts for 2005 to 2011 are in accordance with AIFRS.
Financial amounts for 2002 to 2004 are in accordance with previous GAAP.
** Excludes $5.2m acquisition of core technology from Implex AG Hearing Technology.